Browse > Article
http://dx.doi.org/10.6114/jkood.2016.29.3.059

The Study on the Korean and Western Medical Literatures for Neuroprotection Therapy of Glaucoma  

Jung, Hye-Jin (Dept. of Oriental Medical Opthalmology & Otolaryngology & Dermatology, Dong-eui University)
Ko, Woo-Shin (Dept. of Oriental Medical Opthalmology & Otolaryngology & Dermatology, Dong-eui University)
Yoon, Hwa-Jung (Dept. of Oriental Medical Opthalmology & Otolaryngology & Dermatology, Dong-eui University)
Publication Information
The Journal of Korean Medicine Ophthalmology and Otolaryngology and Dermatology / v.29, no.3, 2016 , pp. 59-73 More about this Journal
Abstract
Objectives : The aim of this study is to understand neuroprotection therapy of glaucoma with both Korean and western medicine.Methods :　 We searched Pubmed on the title "glaucoma" and "neuroprotection" and also searched CNKI(China National Knowledge Infrastructure) and OASIS(Oriental Medicine Advanced Searching Integrated System) on the title "glaucoma".Results : The results are as follows. 1. In western medicine, excitotoxicity inhibition, immunomodulation, oxidative stress suppression, supplement of NTFs and stem cell therapy are studied with neuroprotection therapy of glaucoma. 2. Treatment of glaucoma in TCM and Korean medicine are associated with liver(肝) and kidney(腎).Conclusions : Korean medical approaches on neuroprotection therapy of glaucoma can be significant, and further studies are needed to research.
Keywords
glaucoma; neuroprotection; Korean medicine; review;
Citations & Related Records
연도 인용수 순위
  • Reference
1 Froger N, Cadetti L, Lorach H, Martins J, Bemelmans AP, Dubus E, et al. Taurine provides neuroprotection against retinal ganglion cell degeneration. PLoS One. 2012;7(10):e42017.   DOI
2 Duncan RS, Xin H, Goad DL, Chapman KD, Koulen P. Protection of neurons in the retinal ganglion cell layer against excitotoxicity by the N-acylethanolamine, N-linoleoylethanolamine. Clin Ophthalmol. 2011;5:543-8.
3 Tezel G. Immune regulation toward immunomodulation for neuroprotection in glaucoma. Curr Opin Pharmacol. 2013;13(1): 23-31.   DOI
4 Tezel G. TNF-alpha signaling in glaucomatous neurodegeneration. Prog Brain Res. 2008;173: 409-21.   DOI
5 Yang F, Wang D, Wu L, Li Y. Protective effects of triptolide on retinal ganglion cells in a rat model of chronic glaucoma. Drug Des Devel Ther. 2015;9:6095-107.   DOI
6 Park SW, Lee HS, Sung MS, Kim SJ. The effect of melatonin on retinal ganglion cell survival in ischemic retina. Chonnam Med J. 2012;48(2):116-22.   DOI
7 Madeira MH, Ortin-Martinez A, Nadal-Nícolas F, Ambrósio AF, Vidal-Sanz M, Agudo-Barriuso M, et al. Caffeine administration prevents retinal neuroinflammation and loss of retinal ganglion cells in an animal model of glaucoma. Sci Rep. 2016;6:27532.   DOI
8 Izzotti A, Sacca SC, Cartiglia C, De Flora S. Oxidative deoxyribo-nucleic acid damage in the eyes of glaucoma patients. Am J Med. 2003;114(8):638-46.   DOI
9 Nucci C, Tartaglione R, Cerulli A, Mancino R, Spanò A, Cavaliere F, et al. Retinal damage caused by high intraocular pressure-induced transient ischemia is prevented by coenzyme Q10 in rat. Int Rev Neurobiol. 2007;82:397–406.   DOI
10 Nixon E, Simpkins JW. Neuroprotective effects of nonfeminizing estrogens in retinal photoreceptor neurons. Invest Ophthalmol Vis Sci. 2012;53(8):4739-47.   DOI
11 Cybulska-Heinrich AK, Mozaffarieh M, Flammer J. Ginkgo biloba: an adjuvant therapy for progressive normal and high tension glaucoma. Mol Vis. 2012;18:390-402.
12 Mi XS, Zhong JX, Chang RC, So KF. Research advances on the usage of traditional Chinese medicine for neuroprotection in glaucoma. J Integr Med. 2013;11(4):233-40.   DOI
13 Chan HC, Chang RC, Koon-Ching Ip A, Chiu K, Yuen WH, Zee SY, et al. Neuroprotective effects of Lycium barbarum Lynn on protecting retinal ganglion cells in an ocular hypertension model of glaucoma. Exp Neurol. 2007;203(1):269-73.   DOI
14 Zhu Q, Su G, Nie L, Wang C, He Y, Liu X. Salvia miltiorrhiza extracts protect against retinal injury in a rat glaucoma model. Exp Ther Med. 2014;7(6):1513-5.   DOI
15 Tian K, Shibata-Germanos S, Pahlitzsch M, Cordeiro MF. Current perspective of neuroprotection and glaucoma. Clin Ophthalmol. 2015;9:2109-18.
16 Ko ML, Hu DN, Ritch R, Sharma SC, Chen CF. Patterns of retinal ganglion cell survival after brain-derived neurotrophic factor administration in hypertensive eyes of rats. Neurosci Lett. 2001;305(2):139-42.   DOI
17 Lambiase A, Aloe L, Centofanti M, Parisi V, Báo SN, Mantelli F, et al. Experimental and clinical evidence of neuroprotection by nerve growth factor eye drops: Implications for glaucoma. Proc Natl Acad Sci USA. 2009;106(32):13469-74.   DOI
18 Jiang C, Moore MJ, Zhang X, Klassen H, Langer R, Young M. Intravitreal injections of GDNF-loaded biodegradable microspheres are neuroprotective in a rat model of glaucoma. Mol Vis. 2007;13:1783-92.
19 Deng X, Wang M, Zhang L, Zhang SK. Discussion on TCM treatment of bluish glaucoma(Qingfengneizhang). China Journal of Chinese Ophthalmology. 2012;1:63-5.
20 Johnson TV, Bull ND, Martin KR. Stem cell therapy for glaucoma: possibilities and practicalities. Expert Rev Ophthalmol. 2011;6 (2):165-74.   DOI
21 Dong JX. TCM treatment of glaucoma. Chinese journal of ethnomedicine and ethnopharmacy. 2012;21:95-6.
22 Qiu LX. The Operation of sap metabolism in 《Hwangjenaekyeong》 for TCM treatment of primary acute glaucoma. China Journal of Chinese Ophthalmology. 2015;4:290-2.
23 Gu D, Zhang D, Lu S, He W. Protection Mechanism Research Situation of Tradition Chinese Medicine(TCM) for Glaucoma Optic Nerve and Retinal Ganglion Cells. J of Practical Traditional Chinese Internal Medicine. 2016;30(3):95-7.
24 Xijing. Analysis of the literature of TCM physique characteristics and patients with glaucoma. Shandong University of Traditional Chinese Medicine. 2014.
25 Liu J. Clinical observation of Yijingqijudihuang Granules on the protection of the optic nerve of early glaucoma. China University of Traditional Chinese Medicine. 2012.
26 Zhang G, Wu L, Yang Y, Wu D, Kang W, Wu DL. Clinical study on treating early primary open-angle glaucoma with Qinggaiyiangya Capsule. China Academy of Chinese Medical Sciences. 2015;2:122-5.
27 Li X, Yin LR, Gao JS, Zhang LX, Liu J, Wang MX, et al. Protective effects of kidney-tonifying liver-soothing medicinals on visual function of early glaucoma: a clinical trial. Journal of Beijing University of Traditional Chinese Medicine. 2015;38(2): 134-8.
28 Song LP. The study of treatment with reinforcing kidney and activating blood circulation for primary angle-closure glaucoma. Contemporary Medicine. 2016;22(16):155-6.
29 Yang H, Yin L, Gao JS, Zhang LX, Liu J, Wang MX, et al. Clinical trial of 100 cases on Yijing Buyang Huanwu Decoction in protecting optic nerve of middle-advanced stage glaucoma with qi deficiency and blood stasis syndrome. China Journal of Chinese Ophthalmology. 2015;6:405-8.
30 Gong XH, Wei QP, Zhou J, Sun YH, Su Y, Cao JY. Effect of benefiting qi to activating blood on glaucomatous optic neuropathy. China Journal of Chinese Ophthalmology. 2012;2:113-4.
31 Li X, Wang T, He XZ, X XL. Clinical Observation of Bujing Yishi Tablet Combined Methecobal for Glaucoma of IOP under Control. Liaoning Journal of Traditional Chinese Medicine. 2014;41(9):1793-6.
32 Deng XH, Ye H. Clinical observation of treatment with expelling wind and releasing vacuity heat for glaucoma demonstrated in type of liver depression and blood deficiency. Beijing Journal of Traditional Chinese Medicine. 2013;32(4):293-5.
33 Hu Y, Zhang LX, Su LY, Yang H. Clinical observation on TCM treatment in preventing and treating glaucomatous optic neuropathy. China Journal of Chinese Ophthalmology. 2012;22(5):340-2.
34 Sun XW. Analysis of the Curative Effect of Acupuncture Treatment of Glaucomatous Optic Neuropathy. Clinical Journal of Chinese Medicine. 2015;7(21):84-5.
35 Han B, Liu F. Analysis of the Curative Effect of Comprehensive TCM treatment for 30 cases of primary open-angle glaucoma. Chin J Convalescent Med. 2016;25(4):367-9.   DOI
36 Bao LZ, Yang G, Lu W, Yang LQ, Zhao ZQ, Ren FH. Effect of traditional Chinese medicine and acupuncture on visual function of glaucoma. China Journal of Chinese Ophthalmology. 2013;23(6):417-9.
37 Wu M. Observation of optic nerve protective effect of combined TCM treatment after glaucoma operation. World Latest Medicine Information. 2015;15(32):178-9.
38 Song HL. Development of clinical observation in TCM treatment for glaucoma. J of Clinical Medical Literature. 2015;2(16):3367-70.
39 Li CJ, Zhang CH, Ding LL, Yu JL. Study of optic nerve protective effect of TCM treatment after glaucoma operation. Nei Mongol Journal of Traditional Chinese Medicine. 2014;17:25.
40 Long FZ. Clinical study on optic nerve protective effect of TCM treatment after glaucoma operation. Aisa-Pacific Traditional Medicine. 2014;10(24):73.
41 Lee YW, Choi CY, Bae JH, Kim JM. The effect of Anthocyanoside and Ginko Biloba Extract on normal-tension glaucoma according to presence of diabetes. J Korean Opthalmol Soc. 2014;55(8):1174-9.   DOI
42 Heo J. Donguibogam. 4th ed. Kyeongnam: Donguibogam Chulpansa. 2010:96, 483, 490.
43 Oriental Medical School Physiology professors. Oriental Physiology. 1st ed. Paju: Jipmoondang. 2008:207-8, 290.
44 Oriental Medical School Herbal Medicine Editing Commision. Herbal Medicine. 2nd ed. Seoul:Youngrimsa. 2011:257-8, 458-9, 655-6.
45 Ko WS, Kwon K, Kim KJ, Kim KS, Kim YB, Kim JH, et al. 1st ed. Korean Medicine Ophthalmology. 2015:41.
46 Rho SS. Korean Opthalmology, Otolaryngology. 3th ed. Seoul:Seoul Inshuaesa. 2011:309-10, 317-23.
47 Yoon DH, Lee SW, Choi E. Opthalmology. 6th ed. Seoul:Ilchokak. 2003:230-49.
48 Chang EE, Goldberg JL. Glaucoma 2.0: neuroprotection, neuroregeneration, neuroenhancement. Ophthalmology. 2012;119(5):979-86.   DOI
49 Song W, Huang P, Zhang C. Neuroprotective therapies for glaucoma. Drug Des Devel Ther. 2015;11(9):1469-79.   DOI
50 Kim GJ, Chae BY. A Clinical analysis on glaucoma, cataract and causing-blindness-diseases by oriental medical therapy. J Korean Med Opthalmol Otolaryngol Dermatol. 1997;10(1):340-8.
51 Cheung W, Guo L, Cordeiro MF. Neuroprotection in glaucoma: drug-based approaches. Optom Vis Sci. 2008;85(6):406-16.   DOI
52 Kim YB, Chae BY. A Clinical Study on Glaucoma. J Korean Med Opthalmol Otolaryngol Dermatol. 1995;8(1):143-7.
53 Seo HR, Jin SW, Rho SH. Relationship Between Nocturnal Dip, Carotid Artery Blood Flow, Brain Ischemic Change in Open Angle Glaucoma. J Korean Opthalmol Soc. 2013;54(9):1386-94.   DOI
54 Michael EK. Molecular bilogy of glutamate receptors in the central nervous system and their role in excitotoxicity, oxidative stress and aging. Prog Neurobiol. 1998;54(4): 369-415.   DOI
55 Kim NY, Seo HR, Rho SH. The relationships among Delayed Recovery in Finger Temperature, Nocturnal Dip, and Glaucoma Progression. J Korean Opthalmol Soc. 2015;56(1):70-9.   DOI
56 Kang JH, Park KH, Kim YJ, Kim JH, Kwak WJ. The neuroprotective effect of ginexin on rat retinal ganglion cell in optic nerve crush injury model. J Korean Ophthalmol Soc. 2003;44(4):965-70.
57 Lee SM, Park KH, Seo JS. The efffect of heat shock protein 70.1 gene(hsp70.1) on retinal ganglion cell damage after partial lesion of the optic nerve in mice. J Korean Ophthalmol Soc. 2002;43(12):2577-84.
58 Dreyer EB, Zurakowski D, Schumer RA, Podos SM, Lipton SA. Elevated glutamate levels in the vitreous body of humans and monkeys with glaucoma. Arch Ophthalmol. 1996;114(3):299–305.   DOI
59 Brooks DE, Garcia GA, Dreyer EB, Zurakowski D, Franco-Bourland RE. Vitreous body glutamate concentration in dogs with glaucoma. Am J Vet Res. 1997;58(8):864-7.
60 WoldeMussie E, Yoles E, Schwartz M, Ruiz G, Wheeler LA. Neuroprotective effect of memantine in different retinal injury models in rats. J Glaucoma. 2002;11(6):474-80.   DOI
61 Nucci C, Tartaglione R, Rombolà L, Morrone LA, Fazzi E, Bagetta G. Neurochemical evidence to implicate elevated glutamate in the mechanisms of high intraocular pressure (IOP)-induced retinal ganglion cell death in rat. Neurotoxicology. 2005;26(5):935-41.   DOI
62 Wang Y, Wang Y, Yang Q, Guo L, Yin Y, Fan N, et al. Neuroprotective effects of C3 exoenzyme in excitotoxic retinopathy. Exp Eye Res. 2014;125:128-34.   DOI